Literature DB >> 18528723

NICE continues to muddy the waters of osteoporosis.

J A Kanis, J E Compston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528723     DOI: 10.1007/s00198-008-0649-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  18 in total

1.  NICE recommendations for the prevention of osteoporotic fractures in postmenopausal women.

Authors:  Pierre D Delmas; Ethel S Siris
Journal:  Bone       Date:  2007-11-12       Impact factor: 4.398

2.  Absolute fracture risk reporting in clinical practice: a physician-centered survey.

Authors:  W D Leslie
Journal:  Osteoporos Int       Date:  2008-02-01       Impact factor: 4.507

3.  An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.

Authors:  O Johnell; J A Kanis
Journal:  Osteoporos Int       Date:  2006-09-16       Impact factor: 4.507

Review 4.  Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.

Authors:  J A Kanis; M Stevenson; E V McCloskey; S Davis; M Lloyd-Jones
Journal:  Health Technol Assess       Date:  2007-03       Impact factor: 4.014

Review 5.  Cost-effectiveness of the treatment and prevention of osteoporosis--a review of the literature and a reference model.

Authors:  N Zethraeus; F Borgström; O Ström; J A Kanis; B Jönsson
Journal:  Osteoporos Int       Date:  2006-11-09       Impact factor: 4.507

6.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

7.  The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden.

Authors:  N Zethraeus; O Ström; F Borgström; J A Kanis; B Jönsson
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

8.  Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

Authors:  J A Kanis; E V McCloskey; H Johansson; O Strom; F Borgstrom; A Oden
Journal:  Osteoporos Int       Date:  2008-08-28       Impact factor: 4.507

9.  [Diagnosis and treatment of postmenopausal osteoporosis and osteoporosis in men. German Guidelines Update 2006].

Authors:  A A Kurth; J Pfeilschifter
Journal:  Orthopade       Date:  2007-07       Impact factor: 1.087

10.  Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX).

Authors:  S Fujiwara; T Nakamura; H Orimo; T Hosoi; I Gorai; A Oden; H Johansson; J A Kanis
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

View more
  2 in total

1.  NICE: Its Influence in Treating Osteoporosis in the UK and beyond.

Authors:  Juliet Compston
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

Review 2.  Is osteoporosis disease management cost effective?

Authors:  Richard Dell; Denise Greene
Journal:  Curr Osteoporos Rep       Date:  2010-03       Impact factor: 5.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.